EUVIMEDEUVIMED entdecken
Crossref

Biochemical Ratios for Predicting Primary Hyperparathyroidism: Revisiting Simple yet Powerful Diagnostic Tools

Fatma Tuğçe Şah Ünal iD, Özgür Demir iD, Rıfat Emral iD, Asena Gökçay Canpolat iD

Clinical Endocrinology · 2026

DOI: 10.1111/cen.70052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Endocrinology, 2026. Verfasst von Fatma Tuğçe Şah Ünal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ankara University Faculty of Medicine, Department of Endocrinology and Metabolism, Ankara, Turkiye. Hauptthemen laut MEDLINE: Hyperparathyroidism, Primary. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Differentiating primary hyperparathyroidism (PHPT), normocalcemic PHPT (NPHPT), and vitamin D deficiency‐related secondary hyperparathyroidism (VDSHPT) remains a diagnostic challenge. This study evaluated the utility of biochemical markers in distinguishing these conditions.

Methods

In this cross‐sectional study, 437 participants were categorised into PHPT ( n = 161), NPHPT ( n = 97), VDSHPT ( n = 89), and control ( n = 90) groups. Serum calcium, phosphate, chloride, PTH, and vitamin D levels were analysed, along with indices such as Ca/P, Cl/P, Ca × Cl/P, and the PF Index (Ca × PTH/P).

Results

Calcium levels were highest in PHPT (2.73 ± 0.17 mmol/L), while phosphate levels were lowest (0.70 ± 0.19 mmol/L) both p < 0.001. PTH levels were significantly elevated in PHPT, NPHPT, and VDSHPT versus controls ( p < 0.001). Ca/P ratio was significantly higher in PHPT (4.17 ± 1.21, p < 0.001), as was the Ca × Cl/P ratio (448.5 ± 133.6, p < 0.001). No significant difference was found between NPHPT and VDSHPT groups in Ca/P ( p = 0.63) and Ca × Cl/P ( p = 0.74) ratios. Ca × Cl/P ratio exhibited the highest diagnostic accuracy for PHPT with a specificity of 89.2% and PPV of 82.2%. Ca/P ratio had the highest sensitivity (77.6%) and an NPV of 86.6%. PF Index (AUC: 0.851, 95% CI: 0.816–0.886) and Cl/P ratio (0.766, 95% CI: 0.711–0.820) showed moderate accuracy. In NPHPT, all markers had high sensitivity but poor specificity (1.6%–23.2%).

Conclusion

The Ca × Cl/P and Ca/P ratios demonstrate substantial diagnostic value for PHPT, while biochemical markers exhibited limited specificity in NPHPT. These findings highlight their role in screening but emphasize the need for additional diagnostic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperparathyroidism, PrimaryHumansFemaleCross-Sectional StudiesMaleMiddle AgedCalciumParathyroid HormoneAgedPhosphatesAdultVitamin DBiomarkersVitamin D DeficiencyHyperparathyroidism, Secondary

Stichwörter der Autor:innen

ROC analysisbiochemical markersnormocalcemic hyperparathyroidismparathyroid function indexprimary hyperparathyroidismvitamin D deficiency

Substanzen

CalciumParathyroid HormonePhosphatesVitamin DBiomarkers

Autor:innen und Institutionen

  • Ankara University Faculty of Medicine, Department of Endocrinology and Metabolism, Ankara, Turkiye.

ORCID-Profile: Fatma Tuğçe Şah Ünal, Özgür Demir, Rıfat Emral, Asena Gökçay Canpolat

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Şah Ünal, F. T., Demir, Ö., Emral, R., & Gökçay Canpolat, A. (2026). Biochemical Ratios for Predicting Primary Hyperparathyroidism: Revisiting Simple yet Powerful Diagnostic Tools. Clinical Endocrinology. https://doi.org/10.1111/cen.70052

Vancouver

Şah Ünal FT, Demir Ö, Emral R, Gökçay Canpolat A. Biochemical Ratios for Predicting Primary Hyperparathyroidism: Revisiting Simple yet Powerful Diagnostic Tools. Clinical Endocrinology. 2026. doi:10.1111/cen.70052

BibTeX
@article{ahnal2026,
  author = {Şah Ünal, Fatma Tuğçe and Demir, Özgür and Emral, Rıfat and Gökçay Canpolat, Asena},
  title = {Biochemical Ratios for Predicting Primary Hyperparathyroidism: Revisiting Simple yet Powerful Diagnostic Tools},
  journal = {Clinical Endocrinology},
  year = {2026},
  doi = {10.1111/cen.70052}
}
Kostenlos starten →